Treatment of relapsed and refractory myeloma
Donna Reece(Princess Margaret Cancer Centre), Michael J. Kovacs(Western University), Leah A. Canning, Darrell White(Dalhousie University), Richard LeBlanc(Hôpital Maisonneuve-Rosemont), Heather A. Leitch(University of British Columbia), Andrew R. Belch, Harold Atkins(University of Ottawa), Michael Voralia(University of Saskatchewan)
Cited by 14
Related Papers
Evidence-Based Management of Anticoagulant Therapy
|CHEST Journal|2012|1.3k
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850